Zobrazeno 1 - 10
of 517
pro vyhledávání: '"haploidentical hematopoietic stem cell transplantation"'
Publikováno v:
BMC Pediatrics, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Overt gastrointestinal bleeding (GIB) is a potentially serious and life-threatening condition in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, relatively little information is availab
Externí odkaz:
https://doaj.org/article/0c1d5d2180554d31b4a2dd244b6d3225
Autor:
Dong Hyun Kim, Dong-Yeop Shin, Youngil Koh, Inho Kim, Sung-Soo Yoon, Ja Min Byun, Junshik Hong
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract This study aimed to assess the efficacy of dual T-cell suppression using individually tailored doses of antithymocyte globulin (ATG) and attenuated dose of post-transplant cyclophosphamide (PTCy) in haploidentical hematopoietic stem cell tra
Externí odkaz:
https://doaj.org/article/9e6b3a6008c745668dcce82783a22d7a
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 585-591 (2024)
Zhengqin Tian,1,* Qihang Man,1,* Yixin Yang,1,* Xiaomei Zhang,2,* Hexian Guan,1 Wenjing Gu,2 Ying Wang,1 Dandan Song,2 Rongmu Luo,1,2 Jingbo Wang1 1Department of Hematology, Aerospace Center Hospital, Beijing, People’s Republic of C
Externí odkaz:
https://doaj.org/article/ae4847fc85d340538b2fb0eb18a855be
Autor:
Ruirui Gui, Zhen Li, Juan Wang, Yingling Zu, Binglei Zhang, Juanjuan Zhao, Yongping Song, Jian Zhou
Publikováno v:
Heliyon, Vol 10, Iss 22, Pp e40356- (2024)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective measure for the treatment of hematological disease. With the progress and wide use of allo-HSCT, post-transplant central nervous system complications (CNSC) have gotten mo
Externí odkaz:
https://doaj.org/article/3c193627567d4357958c6642b5f3b854
Autor:
Yuying Wang, Yiou Zhao, Xiaosheng Fang, Dai Yuan, Mei Ding, Kang Lu, Huiting Qu, Na Wang, Xiao Lv, Peipei Li, Changqing Zhen, Hongzhi Xu, Yujie Jiang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionGraft failure (GF) or poor graft function (PGF) remain critical obstacles in haploidentical hematopoietic stem cell transplantation (haplo-HSCT), especially in recipients with HLA antibodies. Here, we performed a retrospective cohort stud
Externí odkaz:
https://doaj.org/article/74b05b17d8c44de18afff766e95d6d96
Publikováno v:
Zhenduanxue lilun yu shijian, Vol 23, Iss 02, Pp 180-183 (2024)
This article reports a case of acute myelomonocytic leukemia (AML-M4, CBFB gene positive) with lower limb microthrombus formation after haploidentical hematopoietic stem cell transplantation, and summarizes the experience of diagnosis and treatment.
Externí odkaz:
https://doaj.org/article/6e04d4ad653044de9fc5990aba1894e6
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Outcomes of haploidentical hematopoietic stem cell transplantation (haplo-SCT) have improved over time. Graft failure and graft-versus-host disease (GVHD), which were important complications in major human leukocyte antigen (HLA)-disparity stem cell
Externí odkaz:
https://doaj.org/article/bd8518eacbb34ab190fea7107096a383
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe human leukocyte antigen (HLA) evolutionary divergence (HED) reflects immunopeptidome diversity and has been shown to predict the response of tumors to immunotherapy. Its impact on allogeneic hematopoietic stem cell transplantation (HS
Externí odkaz:
https://doaj.org/article/274514776a674a298a6f67f2f7dded03
Publikováno v:
陆军军医大学学报, Vol 46, Iss 4, Pp 319-325 (2024)
Objective To investigate the effects of anti-HLA donor-specific antibodies (DSA) and desensitization for DSA+patients on engraftment of haploidentical hematopoietic stem cell transplantation (haplo-HSCT). Methods The patients who underwent haplo-HSCT
Externí odkaz:
https://doaj.org/article/5f541ecabaf34a31a16b866cf77975bb
Autor:
Claire Lacan, Jérôme Lambert, Edouard Forcade, Marie Robin, Patrice Chevallier, Sandrine Loron, Claude-Éric Bulabois, Corentin Orvain, Patrice Ceballos, Etienne Daguindau, Amandine Charbonnier, Yves Chalandon, Marc Bernard, Célestine Simand, Marie-Thérèse Rubio, Pascal Turlure, Johan Maertens, Anne Huynh, Michael Loschi, Jacques-Olivier Bay, Gaëlle Guillerm, Mustafa Alani, Cristina Castilla-Llorente, Xavier Poiré, Sylvain Chantepie, Natacha Maillard, Yves Beguin, Ambroise Marçais, Jérôme Cornillon, Jean-Valère Malfuson, Sébastien Maury, Nathalie Meuleman, Alban Villate, Mohammed-Amine Bekadja, Anouk Walter-Petrich, Nathalie Jacque, Micha Srour, Raynier Devillier, Stéphanie Nguyen
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-5 (2024)
Abstract The use of peripheral blood (PB) or bone marrow (BM) stem cells graft in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis remains controversi
Externí odkaz:
https://doaj.org/article/06528184135d4dc9a33935cb6d4ee598